You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN, June 3, 2020 /PRNewswire/ -- The "Bioanalytical Testing Services Market by Type, Application, End User - Global Forecasts to 2025 " report has been added to ResearchAndMarkets.com's offering. The global bioanalytical testing services market is projected to reach USD 3.72 billion by 2025 from an estimated USD 2.13 billion in 2020, at a CAGR of 11.8% during the forecast period. This report analyzes the bioanalytical testing services market and aims at estimating the market size and future growth potential of various market segments, based on type, application, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, service offerings, recent developments, and key market strategies. Rising focus on the analytical testing of biologics and biosimilars to drive market growth. The growth in this market is attributed to the rising focus on the analytical testing of biologics and biosimilars, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design approach. However, the dearth of skilled professionals is a major factor that is expected to restrain the growth of this market during the forecast period. Pharmaceutical and biopharmaceutical companies were the largest end users of bioanalytical testing services in 2019. Based on end user, the bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, and contract research organizations. In 2019, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the bioanalytical testing services market. The large share of this segment can be attributed to the increased outsourcing of early-phase development, clinical, and laboratory testing services by pharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time duration to validate processes and products. Oncology is the largest application segment in the bioanalytical testing services market. Based on the application area, the bioanalytical testing services market is broadly categorized into oncology, neurology, infectious diseases, gastroenterology, cardiology, and other applications. Oncology is the largest application segment in this market, primarily due to the increasing number of clinical trials conducted for oncology and the rising prevalence of cancer worldwide. North America will continue to dominate the bioanalytical testing services market in 2025. The bioanalytical testing services market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the bioanalytical testing services market. The large share of North America in this market can be attributed to the high-quality standards in the pharmaceutical industry, rapid growth in the biosimilars and biologics markets, and an increase in clinical trial activity in the region. The prominent players operating in the bioanalytical testing services market include Charles River (US), Medpace (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), IQVIA, Inc. (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings (US), Intertek Group plc (UK), PRA Health Sciences (US), Syneos Health (US), ICON plc (Ireland), Frontage Labs (US), PPD, Inc. (US), PAREXEL International Corporation (US), Almac Group (UK), Celerion (US), Altasciences (US), BioAgilytix Labs (US), Lotus Labs Pvt. Ltd. (India), and LGS Limited (UK). Key Topics Covered 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Bioanalytical Testing Services Market Overview4.2 Asia Pacific: Bioanalytical Testing Services Market, by Application & Country (2019)4.3 Bioanalytical Testing Services Market: Geographic Growth Opportunities4.4 Regional Mix: Bioanalytical Testing Services Market4.5 Bioanalytical Testing Services Market: Developing vs. Developed Countries 5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Rising Focus on the Analytical Testing of Biologics and Biosimilars5.2.1.2 Increasing Preference for Outsourcing Analytical Testing5.2.1.3 Growing R&D Expenditure in the Pharmaceutical and Biopharmaceutical Industry5.2.1.4 Rising Adoption of the Quality by Design Approach5.2.2 Restraints5.2.2.1 Dearth of Skilled Professionals5.2.2.2 Pricing Pressure Faced by Major Players5.2.3 Opportunities5.2.3.1 Emerging Countries in the Asia Pacific Region5.2.3.2 Rising Demand for Specialized Bioanalytical Testing Services5.2.4 Challenges5.2.4.1 Innovative Formulations Demanding a Unique Bioanalytical Testing Approach5.2.4.2 Growing Need to Improve the Sensitivity of Bioanalytical Methods 6 Bioanalytical Testing Services Market, by Type6.1 Introduction6.2 Cell-Based Assays6.2.1 Bacterial Cell-Based Assays6.2.1.1 Bacterial Cell-Based Assays Segment to Dominate the Bioanalytical Testing Services Market for Cell-Based Assays6.2.2 Viral Cell-Based Assays6.2.2.1 Increasing Outbreaks of Viral Diseases to Support the Growth of This Market Segment6.3 Virology Testing6.3.1 in Vitro Virology Testing6.3.1.1 Higher Uptake of in Vitro Virology Assays in the Development of Antiviral Pharmaceuticals to Drive the Growth of This Market Segment6.3.2 in Vivo Virology Testing6.3.2.1 High Utilization of in Vivo Assays During Important Production Phases to Drive Their Demand6.3.3 Species-Specific Viral Pcr Assays6.3.3.1 Wide Application of Species-Specific Viral Pcr Assays in the Detection of Viral Risks to Support the Growth of This Market Segment6.4 Method Development Optimization and Validation6.4.1 Mandatory Requirement by Regulatory Authorities to Drive the Growth of This Market Segment6.5 Serology, Immunogenicity, and Neutralizing Antibodies6.5.1 Increasing Applications of Serology, Immunogenicity, and Neutralizing Antibodies to Drive the Growth of This Market Segment6.5.2 Bacterial Serology, Immunogenicity, and Neutralizing Antibodies6.5.3 Viral Serology, Immunogenicity, and Neutralizing Antibodies6.6 Biomarker Testing6.6.1 Emphasis on the Development of Personalized Medicine to Drive the Demand for Biomarker Testing Services6.7 Pharmacokinetic Testing6.7.1 Increasing Incidence of Infectious Diseases to Drive the Demand for Pharmacokinetic Testing Services6.8 Other Services 7 Bioanalytical Testing Services Market, by Application7.1 Introduction7.2 Oncology7.2.1 Oncology is the Largest Application Segment in the Bioanalytical Testing Services Market7.3 Neurology7.3.1 Robust Pipeline of Drugs for Cns Diseases to Drive the Growth of This Market Segment7.4 Infectious Diseases7.4.1 Outbreak of Covid-19 to Boost the Growth of This Market Segment7.5 Gastroenterology7.5.1 Rising Prevalence of Chronic Digestive Disorders to Support the Growth of This Market Segment7.6 Cardiology7.6.1 Increasing Prevalence of Cardiovascular Diseases to Support the Growth of This Market Segment7.7 Other Applications 8 Bioanalytical Testing Services Market, by End User8.1 Introduction8.2 Pharmaceutical and Biopharmaceutical Companies8.2.1 Pharmaceutical and Biopharmaceutical Companies Are the Largest End Users of Bioanalytical Testing Services8.3 Contract Development and Manufacturing Organizations8.3.1 Cdmos Provide Services Such As Analytical Development, Formulation Screening and Development, Stability Studies, and Pre-Clinical Safety Assessment Studies8.4 Contract Research Organizations8.4.1 Contract Research Organizations Are Increasingly Subcontracting Their Activities to Niche Laboratories Specialized in Providing Bioanalytical Testing Services 9 Bioanalytical Testing Services Market, by Region9.1 Introduction9.2 North America9.2.1 US9.2.1.1 US is the Largest Market for Bioanalytical Testing Services in North America9.2.2 Canada9.2.2.1 Increasing Number of Clinical Trials in Canada to Support Market Growth9.3 Europe9.3.1 Germany9.3.1.1 Government Support and Flexible Labor Laws Have Made Germany a Favorable Location for Clinical Trials9.3.2 France9.3.2.1 High Number of Oncology Clinical Trials in France to Drive Market Growth9.3.3 UK9.3.3.1 Investment by Pharmaceutical Sponsors in the UK for Drug Discovery Services to Support Market Growth9.3.4 Italy9.3.4.1 Low Drug Approval Time in Italy, Along with the Growing Number of Clinical Trials, to Drive Market Growth9.3.5 Spain9.3.5.1 Short Study Start-Up Times and Rising R&D Expenditure to Boost the Growth of the Spanish Market9.3.6 Rest of Europe9.4 Asia Pacific9.4.1 China9.4.1.1 China is the Largest Market for Bioanalytical Testing Services in the Asia Pacific9.4.2 Japan9.4.2.1 Rising Geriatric Population to Drive Market Growth in Japan9.4.3 India9.4.3.1 Growing Pharmaceutical Industry in India to Drive Market Growth9.4.4 Rest of Asia Pacific9.5 Latin America9.5.1 Growing R&D Expenditure in the Pharmaceutical and Biopharmaceutical Sector to Drive Market Growth in Latin America9.6 Middle East & Africa9.6.1 Growing Pharmaceutical Industry to Drive Market Growth in the Middle East and Africa 10 Competitive Landscape10.1 Introduction10.2 Competitive Leadership Mapping10.2.1 Visionary Leaders10.2.2 Innovators10.2.3 Dynamic Differentiators10.2.4 Emerging Companies10.3 Bioanalytical Testing Services Market Share Analysis10.4 Bioanalytical Testing Services Market: Geographical Assessment10.5 Competitive Situations & Trends10.5.1 Service Launches (2017-2020)10.5.2 Expansions (2019-2020)10.5.3 Agreements, Partnerships, and Collaborations (2019-2020)10.5.4 Acquisitions (2019)10.5.5 Other Developments (2019) 11 Company Profiles11.1 Charles River11.2 Medpace11.3 Wuxi Apptec11.4 Eurofins Scientific11.5 Iqvia Inc.11.6 SGS SA11.7 Laboratory Corporation of America Holdings11.8 Intertek Group PLC11.9 PRA Health Sciences11.10 Syneos Health11.11 Icon PLC11.12 Frontage Labs11.13 PPD, Inc.11.14 Parexel International Corporation11.15 Almac Group11.16 Celerion11.17 Altasciences11.18 Bioagilytix Labs11.19 Lotus Labs Pvt. Ltd.11.20 LGC Limited For more information about this report visit https://www.researchandmarkets.com/r/e7gzah Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Answer: Global Bioanalytical Testing Services Market Outlook, 2020-2025 - Outbreak of COVID-19 Boosting Infectious Disease Applications